(Total Views: 618)
Posted On: 05/23/2022 1:03:13 PM
Post# of 154977
Not a Pestell Question: I've been watching NWBO since they announced the results of their Phase 3 study re: brain cancer. Some say the results were phenomenal, other aren't as impressed, but I wonder if this "mixed" reception is typical for most heavily-shorted biopharmas, specifically CYDY.
So my question - if our NASH results are as good as Dr Recknor has previously indicated, can we expect a similar reaction in the day/days immediately following the 700 mg study results? I guess my real question is, do the BP-funded shorts have enough $ to keep our SP in the cellar . . .regardless of the results?
I haven't seen that Gamestop documentary on how the hedge funds and shorts were burned, but if there was ever a product to get behind with a similar GME buying frenzy, it would be for a safe, life-saving, life-changing drug like ours.
Looking forward to June!
So my question - if our NASH results are as good as Dr Recknor has previously indicated, can we expect a similar reaction in the day/days immediately following the 700 mg study results? I guess my real question is, do the BP-funded shorts have enough $ to keep our SP in the cellar . . .regardless of the results?
I haven't seen that Gamestop documentary on how the hedge funds and shorts were burned, but if there was ever a product to get behind with a similar GME buying frenzy, it would be for a safe, life-saving, life-changing drug like ours.
Looking forward to June!
(4)
(0)
